Page last updated: 2024-10-28

hydrochlorothiazide and Leukemia P388

hydrochlorothiazide has been researched along with Leukemia P388 in 1 studies

Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.

Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pettit, GR1
Krupa, TS1
Reynolds, RM1

Other Studies

1 other study available for hydrochlorothiazide and Leukemia P388

ArticleYear
Structural biochemistry. 17. Synthesis of tryptophan dipeptides.
    International journal of peptide and protein research, 1979, Volume: 14, Issue:3

    Topics: Amino Acid Sequence; Animals; Dipeptides; Drug Evaluation, Preclinical; Hydrochlorothiazide; Leukemi

1979